Shay Capital »

Axsome Therapeutics shares owned by Shay Capital

Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Shay Capital from 13F filings

Historical chart of Shay Capital investment in Axsome Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Axsome Therapeutics held by Shay Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Axsome Therapeutics by Shay Capital

Quarter filed Position value Share count Share price at filing
2023-06-30 $230k 3.2k 71.86

More positions owned by Shay Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Purecycle Technologies (PCT)
Ishares Silver Tr Ishares (SLV)
Ftai Aviation SHS (FTAI)
Vor Biopharma Com New Call Option
Sable Offshore Corp Com Shs (SOC)
First Solar (FSLR)
Tesla Motors (TSLA)
Warner Bros Discovery Com Ser A (WBD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Alibaba Group Hldg Sponsored Ads (BABA)
Agnc Invt Corp Com reit (AGNC)
Jd.com Spon Ads Cl A (JD)
A2z Cust2mate Solutions Corp (AZ)

View all positions for Shay Capital

Top funds holding Axsome Therapeutics

Vanguard Group
BlackRock
Wellington Management Company
Rtw Investments
Macquarie Group
Geode Capital Management
Invesco
State Street Corporation
FMR
Deep Track Capital
Fairmount Funds Management
Eventide Asset Management
Alethea Capital Management
Susquehanna International
OrbiMed Advisors

View all funds holding Axsome Therapeutics